The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before President-elect Trump’s inauguration. The Centers for Medicare and ...

Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma ... This comes nine years after the company made bold moves overseas as it acquired Actavis’ UK and ...